Lutherville, MD, United States of America

Paul O Ts'o


Average Co-Inventor Count = 2.2

ph-index = 12

Forward Citations = 1,727(Granted Patents)


Location History:

  • Timonium, MD (US) (1977 - 1978)
  • Ellicott City, MD (US) (1998 - 1999)
  • Baltimore, MD (US) (1999)
  • Lutherville, MD (US) (1984 - 2000)

Company Filing History:


Years Active: 1977-2000

Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Paul O Ts'o

Introduction

Paul O Ts'o is a notable inventor based in Lutherville, MD, with a remarkable portfolio of 13 patents. His work primarily focuses on advancements in the field of virology and pharmaceutical formulations. Ts'o's innovative approaches have contributed significantly to the treatment of viral infections, particularly herpes simplex virus type 2 (HSV-2).

Latest Patents

Among his latest patents is the development of an anti-viral and immuno-stimulator polynucleotide duplex. This method involves treating HSV-2 infection by administering an effective amount of a specific polynucleotide intranasally. Another significant patent involves oligonucleotide analogues that exhibit improved stability at acidic pH levels. These acid-resistant oligomers are suitable for oral administration and include formulations for pharmaceutical applications.

Career Highlights

Throughout his career, Paul O Ts'o has made significant strides in the field of medical research. His work at The Johns Hopkins University has been instrumental in advancing the understanding and treatment of viral infections. Ts'o's innovative contributions have garnered attention and respect within the scientific community.

Collaborations

Paul O Ts'o has collaborated with esteemed colleagues, including Paul S Miller and William A Carter. These partnerships have further enhanced the impact of his research and innovations.

Conclusion

In summary, Paul O Ts'o's contributions to the field of virology and pharmaceutical sciences are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical research and improving treatment options for viral infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…